Resumo
This study was developed to evaluate the clinical, hematological, and performance parameters of calves affected by diarrhea caused by the bacterial enteric pathogen Escherichia coli, treated with three different protocols containing sulfonamides. Fourteen Holstein calves were monitored from birth to 60 days of age, and divided into 3 groups. Group 1 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, administered orally (BM), dissolved in 160 ml of water every 24 h; Group 2 (n=4) received IM sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), and Group 3 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, which is made up of 16 g of phthalylsulfathiazole, associated with 2.28 g neomycin sulfate, 1.6 g of pectin, and 80 g of kaolin, dissolved in 160 ml of water and administered every 24 h by mouth, in addition to sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), at a daily dose of 16 mg/kg live weight, through IM injection. During the study, the animals were clinically evaluated, and once they were diagnosed with diarrhea, feces samples were collected to identify the bacterial enteric pathogen, antibiogram, polymerase chain reaction (PCR), and coproparasitological exams. Blood samples were collected to evaluate the hematological profile, and the performance profile was monitored weekly. In the clinical examination, all calves presented a reduction in body temperature (<39.2°C) and some improvement in hydration after treatment (p=0,31). However, group 2 had a better concentration of lymphocytes and TP concerning the other animals, as well as better performance. Besides, E.coli was detected in 100% of feces samples. Thus, the therapeutic protocols with sulfonamides used to treat bovine neonatal diarrhea were effective in the clinical improvement of the animals. Nonetheless, the protocol with systemic therapy using sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil) intramuscularly, provided better performance, with better weight gain, and body development of the animals.(AU)
Este estudo foi desenvolvido com o objetivo de avaliar parâmetros clínicos, hematológicos e zootécnicos de bezerras acometidas por diarreia provocada pelo agente bacteriano Escherichia coli, tratadas com três diferentes protocolos contendo sulfonamidas. Quatorze bezerras da raça Holandês foram monitoradas do nascimento até os 60 dias de vida e divididas em 3 grupos: Grupo 1 (n=5), animais tratados com a dose de 80g de Kaopek®, Ibasa, Brasil, por via oral (VO), dissolvido em 160ml de água a cada 24 horas; Grupo 2 (n=4) receberam sulfadiazina e trimetropim (Ibatrim®, Ibasa, Brasil), na dose de 16mg/Kg de peso vivo, por dia, por via intramuscular (IM); Grupo 3 (n=5) 80g de Kaopek®, Ibasa, Brasil, por VO dissolvido em 160ml de água, a cada 24 horas e com 16mg/Kg de peso vivo, por dia, de sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil), por via IM. Durante o estudo, os animais foram avaliados clinicamente e a partir do diagnóstico de diarreia foram coletadas amostras de fezes para a identificação do agente bacteriano, antibiograma, reação em cadeia da polimerase (PCR) e exames coproparasitológicos. Amostras de sangue foram coletadas para avaliação do perfil hematológico e o perfil zootécnico foi acompanhado semanalmente. No exame clínico, todas as bezerras apresentaram redução na temperatura corporal (<39,2°C) e melhora na hidratação após o período de tratamento (p=0,31), porém o grupo 2 obteve maior concentração de linfócitos e PPT em relação aos demais, assim como melhor desempenho zootécnico, além disso em 100% das amostras de fezes foi detectado E. coli. Sendo assim, os protocolos terapêuticos com sulfonamidas utilizados para o tratamento da diarreia neonatal bovina foram eficazes na melhora clínica dos animais. Porém, o protocolo com terapia sistêmica com sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil) por via intramuscular proporcionou um melhor desempenho zootécnico, com melhor ganho de peso e desenvolvimento corporal dos animais.(AU)
Assuntos
Animais , Bovinos , Bovinos/microbiologia , Bovinos/sangue , Escherichia coli , Reação em Cadeia da Polimerase , Técnicas de Laboratório ClínicoResumo
This study was developed to evaluate the clinical, hematological, and performance parameters of calves affected by diarrhea caused by the bacterial enteric pathogen Escherichia coli, treated with three different protocols containing sulfonamides. Fourteen Holstein calves were monitored from birth to 60 days of age, and divided into 3 groups. Group 1 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, administered orally (BM), dissolved in 160 ml of water every 24 h; Group 2 (n=4) received IM sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), and Group 3 (n=5) animals were treated with 80 g of Kaopek®, Ibasa, Brazil, which is made up of 16 g of phthalylsulfathiazole, associated with 2.28 g neomycin sulfate, 1.6 g of pectin, and 80 g of kaolin, dissolved in 160 ml of water and administered every 24 h by mouth, in addition to sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil), at a daily dose of 16 mg/kg live weight, through IM injection. During the study, the animals were clinically evaluated, and once they were diagnosed with diarrhea, feces samples were collected to identify the bacterial enteric pathogen, antibiogram, polymerase chain reaction (PCR), and coproparasitological exams. Blood samples were collected to evaluate the hematological profile, and the performance profile was monitored weekly. In the clinical examination, all calves presented a reduction in body temperature (<39.2°C) and some improvement in hydration after treatment (p=0,31). However, group 2 had a better concentration of lymphocytes and TP concerning the other animals, as well as better performance. Besides, E.coli was detected in 100% of feces samples. Thus, the therapeutic protocols with sulfonamides used to treat bovine neonatal diarrhea were effective in the clinical improvement of the animals. Nonetheless, the protocol with systemic therapy using sulfadiazine and trimethoprim (Ibatrim®, Ibasa, Brazil) intramuscularly, provided better performance, with better weight gain, and body development of the animals.(AU)
Este estudo foi desenvolvido com o objetivo de avaliar parâmetros clínicos, hematológicos e zootécnicos de bezerras acometidas por diarreia provocada pelo agente bacteriano Escherichia coli, tratadas com três diferentes protocolos contendo sulfonamidas. Quatorze bezerras da raça Holandês foram monitoradas do nascimento até os 60 dias de vida e divididas em 3 grupos: Grupo 1 (n=5), animais tratados com a dose de 80g de Kaopek®, Ibasa, Brasil, por via oral (VO), dissolvido em 160ml de água a cada 24 horas; Grupo 2 (n=4) receberam sulfadiazina e trimetropim (Ibatrim®, Ibasa, Brasil), na dose de 16mg/Kg de peso vivo, por dia, por via intramuscular (IM); Grupo 3 (n=5) 80g de Kaopek®, Ibasa, Brasil, por VO dissolvido em 160ml de água, a cada 24 horas e com 16mg/Kg de peso vivo, por dia, de sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil), por via IM. Durante o estudo, os animais foram avaliados clinicamente e a partir do diagnóstico de diarreia foram coletadas amostras de fezes para a identificação do agente bacteriano, antibiograma, reação em cadeia da polimerase (PCR) e exames coproparasitológicos. Amostras de sangue foram coletadas para avaliação do perfil hematológico e o perfil zootécnico foi acompanhado semanalmente. No exame clínico, todas as bezerras apresentaram redução na temperatura corporal (<39,2°C) e melhora na hidratação após o período de tratamento (p=0,31), porém o grupo 2 obteve maior concentração de linfócitos e PPT em relação aos demais, assim como melhor desempenho zootécnico, além disso em 100% das amostras de fezes foi detectado E. coli. Sendo assim, os protocolos terapêuticos com sulfonamidas utilizados para o tratamento da diarreia neonatal bovina foram eficazes na melhora clínica dos animais. Porém, o protocolo com terapia sistêmica com sulfadiazina e trimetoprim (Ibatrim®, Ibasa, Brasil) por via intramuscular proporcionou um melhor desempenho zootécnico, com melhor ganho de peso e desenvolvimento corporal dos animais.(AU)
Assuntos
Animais , Bovinos , Bovinos/microbiologia , Bovinos/sangue , Escherichia coli , Reação em Cadeia da Polimerase , Técnicas de Laboratório ClínicoResumo
Background: Poisoning by Xanthium spp. plants are important causes of deaths of cattle in the state of Rio Grande do Sul. This plant has as toxic principle a triterpenoide glycoside that acts inhibiting the transport of adenosine diphosphate and adenosine triphosphate across the mitochondrial membrane, responsible for causing acute liver failure. Clinical signs occur within hours of ingesting the plant. However, the knowledge of the metabolic disorders that these animals suffer are poorly described, so the objective of the reports is to describe an outbreak of spontaneous intoxication by Xanthium cavanillesii and demonstrate the clinical, metabolic and anatomopathological changes of a poisoned bovine. Case: An 8-month-old male bovine, Aberdeen Angus breed, was sent to the Veterinary Hospital of Clinics of Federal University of Pelotas (HCV-UFPel). The animal came from a property located in the southern region of Rio Grande do Sul, belonged to a herd of 506 animals, of which 258 were nulliparous cows and 248 calves, in total 92 died, being 20 cows and 62 calves in a period of 3 days. The clinical course ranged from 3 to 72 h and was characterized by neurological signs (pedaling movements, opisthotonus and motor incoordination), sternal decubitus, muscle tremors, apathy, anorexia, hypersalivation, dehydration, tenesmus and death. In the field where the animals were, there was the present of Xanthium cavanillesii in the dicotyledonouns sprouting phase, with signs of ingestion. During the clinical examination of the animal sent to the hospital, sternal decubitus, muscle tremor, motor incoordination, apathy, anorexia, hypersalivation and opisthotone were observed, heart rate of 60 beats per min, respiratory rate of 15 movements per min, 2 ruminal movements incomplete at every 2 min, moderate dehydration and temperature...(AU)
Assuntos
Animais , Masculino , Bovinos , Xanthium/toxicidade , Intoxicação por Plantas/veterinária , Plantas Tóxicas , Surtos de Doenças/veterináriaResumo
Background: Poisoning by Xanthium spp. plants are important causes of deaths of cattle in the state of Rio Grande do Sul. This plant has as toxic principle a triterpenoide glycoside that acts inhibiting the transport of adenosine diphosphate and adenosine triphosphate across the mitochondrial membrane, responsible for causing acute liver failure. Clinical signs occur within hours of ingesting the plant. However, the knowledge of the metabolic disorders that these animals suffer are poorly described, so the objective of the reports is to describe an outbreak of spontaneous intoxication by Xanthium cavanillesii and demonstrate the clinical, metabolic and anatomopathological changes of a poisoned bovine. Case: An 8-month-old male bovine, Aberdeen Angus breed, was sent to the Veterinary Hospital of Clinics of Federal University of Pelotas (HCV-UFPel). The animal came from a property located in the southern region of Rio Grande do Sul, belonged to a herd of 506 animals, of which 258 were nulliparous cows and 248 calves, in total 92 died, being 20 cows and 62 calves in a period of 3 days. The clinical course ranged from 3 to 72 h and was characterized by neurological signs (pedaling movements, opisthotonus and motor incoordination), sternal decubitus, muscle tremors, apathy, anorexia, hypersalivation, dehydration, tenesmus and death. In the field where the animals were, there was the present of Xanthium cavanillesii in the dicotyledonouns sprouting phase, with signs of ingestion. During the clinical examination of the animal sent to the hospital, sternal decubitus, muscle tremor, motor incoordination, apathy, anorexia, hypersalivation and opisthotone were observed, heart rate of 60 beats per min, respiratory rate of 15 movements per min, 2 ruminal movements incomplete at every 2 min, moderate dehydration and temperature...